Skip to main content

Table 1 Clinical characteristics of patients with MSA and healthy controls in microarray analysis

From: Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson’s disease

  N Female Male Age, yr. (mean ± S.E.) Disease duration, yr. (mean ± S.E.) UMSARS (mean ± S.E.)
Part 1 Part 2 Part 3 (ΔsBP) Part 3 (ΔdBP) Part 4
MSA 13 7 (53.8%) 6 (46.2%) 62.64 ± 1.97 2.67 ± 0.30 18.18 ± 1.45 16.45 ± 2.46 −28.15 ± 7.16 −9.62 ± 4.81 2.36 ± 0.37
Control 6 3 (50.0%) 3 (50.0%) 60.67 ± 0.80
  1. MSA multiple system atrophy, UMSARS Unified Multiple System Atrophy Rating Scale, ΔsBP systolic blood pressure reduction on standing, ΔdBP diastolic blood pressure reduction on standing, S.E. standard error